During the past decade, CEDOES conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CEDOES" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "R-Pharm International, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Ache Laboratorios Farmaceuticos S.A." with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEDOES" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CEDOES" are "Obesity" (4 trials), "Overweight" (4 trials), "Rheumatoid Arthritis" (3 trials), "Heart Failure" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "CEDOES" in a lesser frequency.

Most popular intervention types in "CEDOES" are "Drug" (22 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Tirzepatide" (7 trials), "Empagliflozin" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "CEDOES" are 23 trials for "All" genders.

Currently, there are NaN active trials in "CEDOES". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in CEDOES, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CEDOES, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".